These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 10905235)
21. [Study of personal best value of peak expiratory flow in patients with asthma--comparison of the highest value of daily PEF under good control and the highest value of daily PEF obtained after using repeated inhaled beta2-agonist during high-dose inhaled steroid treatment]. Watanabe N; Makino S; Kihara N; Fukuda T Arerugi; 2008 Dec; 57(12):1284-92. PubMed ID: 19169083 [TBL] [Abstract][Full Text] [Related]
22. Three generations of ongoing controversies concerning the use of short acting beta-agonist therapy in asthma: a review. Jalba MS J Asthma; 2008; 45(1):9-18. PubMed ID: 18259990 [TBL] [Abstract][Full Text] [Related]
23. Asthma control during and after cessation of regular beta 2-agonist treatment. Wahedna I; Wong CS; Wisniewski AF; Pavord ID; Tattersfield AE Am Rev Respir Dis; 1993 Sep; 148(3):707-12. PubMed ID: 8103655 [TBL] [Abstract][Full Text] [Related]
24. [The management of chronic asthma with inhaled beta 2 agonists--regular use? symptomatic use?]. Kitamura S; Sugama Y Nihon Rinsho; 1996 Nov; 54(11):3078-80. PubMed ID: 8950958 [TBL] [Abstract][Full Text] [Related]
25. Inhaled corticosteroids, combined with long-acting beta(2)-agonists, improve the perception of bronchoconstriction in asthma. Bijl-Hofland ID; Cloosterman SG; Folgering HT; van den Elshout FJ; van Weel C; van Schayck CP Am J Respir Crit Care Med; 2001 Sep; 164(5):764-9. PubMed ID: 11549530 [TBL] [Abstract][Full Text] [Related]
26. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma. Kesten S; Chapman KR; Broder I; Cartier A; Hyland RH; Knight A; Malo JL; Mazza JA; Moote DW; Small P Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):622-5. PubMed ID: 1892303 [TBL] [Abstract][Full Text] [Related]
27. Inhaled salmeterol and salbutamol in asthmatic patients. An evaluation of asthma symptoms and the possible development of tachyphylaxis. Ullman A; Hedner J; Svedmyr N Am Rev Respir Dis; 1990 Sep; 142(3):571-5. PubMed ID: 1975162 [TBL] [Abstract][Full Text] [Related]
28. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study. Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690 [TBL] [Abstract][Full Text] [Related]
29. [The effect of a single dose of formoterol using an aerosol inhaler in asthmatic children. A randomized, controlled, double-blind study]. Lebecque P; Vliers S; De Saint-Moulin T; Godding V Rev Mal Respir; 1994; 11(1):47-50. PubMed ID: 7907426 [TBL] [Abstract][Full Text] [Related]
30. Adverse effects of short-acting beta-agonists: potential impact when anti-inflammatory therapy is inadequate: comment. Ameredes BT Respirology; 2004 Nov; 9(4):570-1. PubMed ID: 15612975 [No Abstract] [Full Text] [Related]
31. Salmeterol for the treatment of asthma. Weinberger M Ann Allergy Asthma Immunol; 1995 Sep; 75(3):209-11. PubMed ID: 7552921 [No Abstract] [Full Text] [Related]
32. A comparison of salmeterol with albuterol in the treatment of mild-to-moderate asthma. Pearlman DS; Chervinsky P; LaForce C; Seltzer JM; Southern DL; Kemp JP; Dockhorn RJ; Grossman J; Liddle RF; Yancey SW N Engl J Med; 1992 Nov; 327(20):1420-5. PubMed ID: 1357554 [TBL] [Abstract][Full Text] [Related]
33. [Are there any advantages of a fixed combination in the treatment of asthma with respect to safety and tolerability?]. Virchow C Dtsch Med Wochenschr; 2009 Dec; 134 Suppl 10():S376-80. PubMed ID: 19941240 [No Abstract] [Full Text] [Related]
34. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study. Busse W; Levine B; Andriano K; Lavecchia C; Yegen U Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475 [TBL] [Abstract][Full Text] [Related]
35. First-line therapy for adult patients with acute asthma receiving a multiple-dose protocol of ipratropium bromide plus albuterol in the emergency department. Rodrigo GJ; Rodrigo C Am J Respir Crit Care Med; 2000 Jun; 161(6):1862-8. PubMed ID: 10852758 [TBL] [Abstract][Full Text] [Related]
36. [Efficacy of salmeterol in patients with allergic bronchial asthma]. Pacor ML; Biasi D; Cortina P; Maleknia T; Lunardi C Clin Ter; 1994 Aug; 145(8):131-4. PubMed ID: 7955958 [TBL] [Abstract][Full Text] [Related]
37. Safety of salmeterol in the maintenance treatment of asthma. Nathan RA; Seltzer JM; Kemp JP; Chervinsky P; Alexander WJ; Liddle R; Mills R Ann Allergy Asthma Immunol; 1995 Sep; 75(3):243-8. PubMed ID: 7552926 [TBL] [Abstract][Full Text] [Related]
38. (R)-albuterol for asthma: pro [a.k.a. (S)-albuterol for asthma: con]. Ameredes BT; Calhoun WJ Am J Respir Crit Care Med; 2006 Nov; 174(9):965-9; discussion 972-4. PubMed ID: 17060667 [TBL] [Abstract][Full Text] [Related]
39. [Long-term effects of inhaled beta 2-agonists on bronchial hyperresponsiveness in asthmatics]. Ogawa C; Sano Y Nihon Rinsho; 1996 Nov; 54(11):3081-6. PubMed ID: 8950959 [TBL] [Abstract][Full Text] [Related]
40. Maintaining asthma control in persistent asthma: comparison of three strategies in a 6-month double-blind randomised study. Godard P; Greillier P; Pigearias B; Nachbaur G; Desfougeres JL; Attali V Respir Med; 2008 Aug; 102(8):1124-31. PubMed ID: 18606533 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]